
Jens Lundgren
@ProfJLundgren
Followers
6K
Following
3K
Media
109
Statuses
3K
Professor, infektionsmediciner, forsker, ekspert, lidende immunsystem, (pan)epidemier, COVID-19, HIV, influenza, +4535455763
Rigshosp. Univ of Copenhagen
Joined December 2014
CHIP laver internationalt anerkendt forskning om hvordan mennesker med lidende immunsystem får et længere og sundere liv / CHIP do internationally recognised research aimed at people with affected immune system on how best to improve their health and extend life. #Rigshospitalet.
33
2
70
RT @EdKrassen: Holy Cow!. Denmark’s Prime Minister Mette Frederiksen just sent a very stern, serious and condemning message to Donald Trump….
0
10K
0
RT @RasmusJarlov: Yesterday, the US vice-president called Denmark a bad ally and repeated the threat of a hostile take-over of Greenland.….
0
4K
0
Henrik: at pressen misinformerer er efterhånden en del af problemet- se mit reaktion på BBC seneste kommunikation på @bluesky
0
0
1
Haft besøg af journalist Johan Rasmussen fra Gymnasieskolen, der gerne ville høre hvad jeg tænkte var spændende ved naturvidenskab. Det er der kommet denne artikel ud af. Måske noget at videregive til yngre der er i tvivl ?.
gymnasieskolen.dk
1
1
11
Har en streng om #IDWeek2024 og gennembrud i beskyttelse mod RSV. Har en sidste pointe ved monoklonale antistoffer til nyfødte der nu kan gives en gang Per 6 mdr og virker - Chile har indført dem og de virker - som forventet 👌
4
2
14
#IDWeek2024 (ID=infectious diseases) foregår i år i LA - hvor crypto har overtaget Stable stadium= Lakers spillested. Ærestaler var Barney Graham - NIAID vaccine center- lavede grundvidenskaben til vacciner mod fx RSV og Sars-Cov-2; fik stabiliseret virus proteinerne.
1
0
1
RSV vaccine RWD: virker tilsyneladende også overfor alvorlig RSV infektion; længde af virkning og behov for boost ukendt. Flere data fra #IDWeek2024 om RSV vaccine & NMab tilføjes i denne streng.
thelancet.com
Respiratory syncytial virus vaccination was effective in preventing respiratory syncytial virus-associated hospitalisations and emergency department encounters among adults aged at least 60 years in...
1
2
18
A novel SARS-CoV-2 recombinant transmitted from a patient with an acute co-infection - The Lancet Microbe
thelancet.com
Recombination occurs in typical coronavirus replication1 and has shaped the SARS-CoV-2 landscape, as shown by the global spread of the recombinant XBB-lineage during 2022 and 2023; however, the...
0
0
1
Interesting study on new antiviral small molecule against RSV among infants. Appears to have clinical effects although more discussion is required for choice of primary endpoint; sample size was small. Needs a repeat.
nejm.org
Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the treatmen...
0
0
2
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 - a more nuanced picture
thelancet.com
This study presents the first comprehensive assessment of the global burden of AMR from 1990 to 2021, with results forecasted until 2050. Evaluating changing trends in AMR mortality across time and...
0
0
7